e-learning
resources
Vienna 2012
Sunday, 02.09.2012
Healthcare utilisation and treatment of asthma and COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Relative exposure to inhaled steroids (ratio "ICS-to-total asthma therapy"): Concordant data from electronic medical records, claims data and patient-reported outcomes
L. Laforest, I. Licaj, G. Devouassoux, G. Chamba, L. Letrilliart, G. Chatte, E. Van Ganse (Lyon, Caluire, France)
Source:
Annual Congress 2012 - Healthcare utilisation and treatment of asthma and COPD
Session:
Healthcare utilisation and treatment of asthma and COPD
Session type:
Thematic Poster Session
Number:
998
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Laforest, I. Licaj, G. Devouassoux, G. Chamba, L. Letrilliart, G. Chatte, E. Van Ganse (Lyon, Caluire, France). Relative exposure to inhaled steroids (ratio "ICS-to-total asthma therapy"): Concordant data from electronic medical records, claims data and patient-reported outcomes. Eur Respir J 2012; 40: Suppl. 56, 998
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Is data quality more important than data quantity in the diagnosis of occupational asthma from serial PEF records?
Source: Annual Congress 2010 - Occupational and environmental exposures and respiratory disease
Year: 2010
Patterns of risk of death and asthma-related adverse outcomes in adult asthma patients receiving long-acting β
2
-agonist (LABA) therapy: results from the UK general practice research database (GPRD)
Source: Annual Congress 2009 - Asthma treatment and control strategies in primary care
Year: 2009
The use of an electronic health record improves asthma clinical outcomes
Source: Annual Congress 2010 - Management of airway disease
Year: 2010
Oral corticosteroids in asthma exacerbations: Differences between patient-reported data and proxies from claims data
Source: International Congress 2016 – Asthma: treatment, disease control, and quality of life
Year: 2016
Change in asthma management recommendations is associated with reduction of reliever drugs in the real-world setting: a longitudinal retrospective claims data analysis in Burgenland
Source: Virtual Congress 2020 – Inhaled corticosteroids and bronchodilator studies in asthma
Year: 2020
Asthma drug ratios and exacerbations: claims data from universal health coverage systems
Source: Eur Respir J 2014; 43: 1378-1386
Year: 2014
Dispensed asthma therapy and medical resource utilisation in asthma patients: results from the L777 observational study
Source: Annual Congress 2009 - Epidemiology of asthma
Year: 2009
SABINA: global programme to evaluate prescriptions and clinical outcomes related to short-acting ß
2
-agonist use in asthma
Source: Eur Respir J, 55 (2) 1901858; 10.1183/13993003.01858-2019
Year: 2020
Defining asthma and assessing asthma outcomes using electronic health record data: a systematic scoping review
Source: Eur Respir J, 49 (6) 1700204; 10.1183/13993003.00204-2017
Year: 2017
Costs of a methodology applied to the ambulatory follow up of patients with continuous asthma in a primary care practice. An observational study using an electronic record with data base linked by the internet
Source: Eur Respir J 2006; 28: Suppl. 50, 209s
Year: 2006
Incident asthma surveillance using electronic medical record (EMR) data
Source: Annual Congress 2009 - Epidemiology of COPD and infectious lung diseases
Year: 2009
An electronic health record improves outcomes in asthmatics outpatients
Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of pulmonary diseases II
Year: 2008
Diagnosis of occupational asthma from serial plots of PEF; first year results of open access to the Oasys internet database
Source: Annual Congress 2011 - The work environment in the clinic
Year: 2011
New sources of data in paediatric asthma: towards big data from multiple sources in children with asthma
Source: Virtual Congress 2021 – New technologies for the management of children with respiratory diseases
Year: 2021
Persistence to COPD therapies and impact on exacerbations: a French claims data study
Source: International Congress 2018 – Respiratory epidemiology: from COPD to factors that associate with lung function and infections
Year: 2018
A comparison of the management of COPD exacerbations in six European hospitals: demographics and baseline data
Source: Annual Congress 2008 - Management of COPD
Year: 2008
Does adherence to inhaled corticosteroids predict asthma-related outcomes over time? A cohort study
Source: Eur Respir J, 54 (6) 1900901; 10.1183/13993003.00901-2019
Year: 2019
Cost impact of time to initiation of triple therapy in COPD patients in Japan: A retrospective analysis of healthcare claims data
Source: International Congress 2017 – Does economisation of medicine transfer into benefits for patients?
Year: 2017
Global asthma physician & patient (GAPP) survey: satisfaction with current asthma medications in Europe – adult findings
Source: Annual Congress 2006 - New developments in the management of asthma
Year: 2006
Asthma severity, poor control, co-morbidities and prior resource use determined omalizumab prescriptions in a nested case-control study with US claims data
Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept